当前位置:首页 - 行情中心 - 欧林生物(688319) - 财务分析 - 现金流量表

欧林生物

(688319)

  

流通市值:112.30亿  总市值:112.30亿
流通股本:4.05亿   总股本:4.05亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金323,403,396.72130,972,177.88641,599,397.99425,324,997.51
  收到其他与经营活动有关的现金19,773,174.735,988,547.8729,217,496.1614,729,823.6
  经营活动现金流入小计343,176,571.45136,960,725.75670,816,894.15440,054,821.11
  购买商品、接受劳务支付的现金29,983,973.9510,871,506.8639,402,719.7428,939,100.74
  支付给职工以及为职工支付的现金55,369,923.8236,455,088.02102,152,012.1379,077,061.07
  支付的各项税费107,380,478.6322,102,942.5652,136,375.933,371,389.25
  支付其他与经营活动有关的现金220,843,121.5392,955,776.82371,632,009.02265,622,035.11
  经营活动现金流出小计413,577,497.93162,385,314.26565,323,116.79407,009,586.17
  经营活动产生的现金流量净额-70,400,926.48-25,424,588.51105,493,777.3633,045,234.94
二、投资活动产生的现金流量:
  收回投资收到的现金135,000,000135,000,000200,000,00095,000,000
  取得投资收益收到的现金125,136.99125,136.99497,841.77259,436.3
  处置固定资产、无形资产和其他长期资产收回的现金净额--27,730.827,730.8
  投资活动现金流入小计135,125,136.99135,125,136.99200,525,572.5795,287,167.1
  购建固定资产、无形资产和其他长期资产支付的现金24,608,881.0922,909,127.3698,811,383.2667,669,448.69
  投资支付的现金135,000,000135,000,000224,209,072.32125,100,000
  投资活动现金流出小计159,608,881.09157,909,127.36323,020,455.58192,769,448.69
  投资活动产生的现金流量净额-24,483,744.1-22,783,990.37-122,494,883.01-97,482,281.59
三、筹资活动产生的现金流量:
  取得借款收到的现金134,000,00020,000,000176,100,000125,000,000
  筹资活动现金流入小计134,000,00020,000,000176,100,000125,000,000
  偿还债务支付的现金39,704,32015,530,000114,720,000102,310,000
  分配股利、利润或偿付利息支付的现金8,442,519.634,120,229.3714,716,571.5910,605,464.35
  支付其他与筹资活动有关的现金11,684,996.576,453,170.4922,263,172.242,138,263.2
  筹资活动现金流出小计59,831,836.226,103,399.86151,699,743.83115,053,727.55
  筹资活动产生的现金流量净额74,168,163.8-6,103,399.8624,400,256.179,946,272.45
五、现金及现金等价物净增加额-20,716,506.78-54,311,978.747,399,150.52-54,490,774.2
  加:期初现金及现金等价物余额225,175,981.53225,175,981.53217,776,831.01217,776,831.01
  期末现金及现金等价物余额204,459,474.75170,864,002.79225,175,981.53163,286,056.81
补充资料:
  净利润-32,879,690.92-21,898,737.19-
  资产减值准备-4,024,665.1-13,585,517.39-
  固定资产和投资性房地产折旧19,252,815.53-33,178,368.49-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧19,252,815.53-33,178,368.49-
  无形资产摊销691,620.93-1,531,603.18-
  长期待摊费用摊销1,602,907.24-4,105,544.24-
  处置固定资产、无形资产和其他长期资产的损失---8,707.5-
  财务费用8,587,518.84-14,987,126.18-
  投资损失-125,136.99--497,841.77-
  递延所得税-1,922,352.32--762,860.6-
  其中:递延所得税资产减少-4,090,759.19--6,698,699.4-
    递延所得税负债增加2,168,406.87-5,935,838.8-
  存货的减少1,790,196.64-9,713,212.89-
  经营性应收项目的减少-99,817,678.59--84,654,805.22-
  经营性应付项目的增加27,912,333.27-75,133,339.27-
  现金的期末余额204,459,474.75-225,175,981.53-
  减:现金的期初余额225,175,981.53-217,776,831.01-
  现金及现金等价物的净增加额-20,716,506.78-7,399,150.52-
公告日期2026-08-182026-04-302026-03-312025-10-30
审计意见(境内)标准无保留意见
TOP↑